Recurrent hepatotoxicity associated with etanercept and adalimumab but not with infliximab in a patient with rheumatoid arthritis Hepatotoxicidad recurrente asociada a etanercept y adalimumab pero no a infliximab en una paciente con artritis reumatoide
